Aquablation procedure safe for BPH, with durable efficacy
For men with large prostates, the Aquablation procedure is safe, with durable efficacy, according to a study published online April 28 in The Journal of Urology.
May 31, 2023
0
2
For men with large prostates, the Aquablation procedure is safe, with durable efficacy, according to a study published online April 28 in The Journal of Urology.
May 31, 2023
0
2
A new genomic urine test can predict bladder cancer as many as 12 years before clinical signs and symptoms emerge, according to a study presented at the annual meeting of the American Urological Association, held from April ...
May 15, 2023
0
3
For patients with kidney stones measuring one to two centimeters, a technique called mini-percutaneous nephrolithotomy (mini-PCNL) provides a higher stone elimination rate than another minimally invasive procedure called ...
May 10, 2023
0
2
A longstanding approach to surgeries for children with kidney tumors has been an abundance of caution.
May 1, 2023
0
11
For patients with advanced bladder cancer who are medically unfit for standard treatment, a new intravesical (inside the bladder) chemotherapy delivery system called TAR-200 is safe and shows initial evidence of effectiveness, ...
Apr 7, 2023
0
11
The rising use of improvised explosive devices (IEDs) has resulted in thousands of service members emerging from combat zones without working sex organs or any chance of having biological children, according to a new study ...
Apr 3, 2023
0
2
A rapid genetic testing model for patients with advanced prostate cancer can more quickly identify those with "actionable" gene variants eligible for newer targeted therapies, reports a clinical trial in The Journal of Urology.
Mar 29, 2023
0
3
Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with non-metastatic castration-resistant prostate ...
Feb 10, 2023
0
3
A new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs, according to a study published in the ...
Feb 9, 2023
0
1
For men with early-stage prostate cancer being managed by active surveillance, adding the hormonal agent apalutamide may lower the rate of positive biopsies during follow-up, suggests a preliminary clinical trial in the Journal ...
Jan 10, 2023
0
4